Heron Therapeutics, Inc.HRTXNASDAQ
Loading
Current Ratio Over TimeNormalizing
Percentile Rank29
3Y CAGR-0.2%
5Y CAGR-4.2%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
-0.2%/yr
vs -15.4%/yr prior
5Y CAGR
-4.2%/yr
Recent acceleration
Acceleration
+15.1pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.48 | +8.4% |
| 2024 | 2.29 | -3.5% |
| 2023 | 2.37 | -5.0% |
| 2022 | 2.49 | -30.3% |
| 2021 | 3.58 | +16.8% |
| 2020 | 3.07 | -38.1% |
| 2019 | 4.95 | +1.9% |
| 2018 | 4.86 | +119.9% |
| 2017 | 2.21 | +37.8% |
| 2016 | 1.60 | - |